ADAM10 has α-secretase activity, which prevents amyloid-β formation [45, 46], and loss-of-function mutations in ADAM10 have been reported in AD patients, indicating that ADAM10 activation may be useful for the treatment of AD [47]. Here, ADAM10 is linked to Alzheimer disease.